###### What are the new findings?

-   It is feasible to conduct a supervised and individualised physical exercise intervention during paediatric cancer treatment.

-   Strenuous physical exercise and physiological testing during paediatric cancer treatment is safe.

-   Cardiorespiratory fitness and function is significantly lower than norms from age-matched healthy children at diagnosis, during treatment and after treatment.

###### How might it impact on clinical practice in the future?

-   Rehabilitation should start at diagnosis to preserve physical function and healthy habits.

-   Physical exercise and activity during anticancer therapy should be promoted.

Background {#s1}
==========

Increased understanding of childhood cancer biology, improved surgical techniques and intensified risk-group-adapted chemotherapy and radiotherapy have led to a 5-year overall survival rate above 80% in childhood cancer.[@R1] However, this improvement comes at a cost. The combination of intensive treatment, severe side effects and isolation regimens, as well as immunosuppression and a treatment-related sedentary lifestyle, compromises the activity level of the children.[@R1] In addition, participation in physical activity with peers is reduced.[@R1] This negatively impacts the children's emotional well-being and health-related quality of life.[@R5] Few studies have addressed physical activity levels in children with cancer. Most studies have relatively small sample sizes, cover only cancer subsets and describe diverse exercise interventions, outcome measurements and durations.[@R7] Overall, the studies indicate that children with cancer are less physically active and have decreased muscle strength, balance and cardiorespiratory fitness during and even years after cessation of treatment compared with their peers.[@R7] A long-term decline in physical fitness can lead to metabolic disease, and previous studies have shown associations between cardiorespiratory fitness and single cardiovascular disease risk factors in childhood.[@R14] However, this can be moderated by physical activity.[@R14] Of paramount importance is the link between fitness and parameters that influence cancer cells, for example, insulin sensitivity and the immune system.[@R16] Animal studies have indicated that physical activity inhibits cancer cell growth.[@R18]

It is unknown whether it is possible to implement a safe and feasible physical exercise intervention during the very intensive treatment regimens for childhood cancer and the concomitant decline in physical capacity, strength and function. Participation in physical activity may cause sore muscles and stress injuries. However, there are no reports in the existing literature on such injuries due to physical training in children with cancer. Thus, the level of intensity at which children with cancer can exercise is uncertain.

The aim of this study was to describe physical capacity and functionality in children with cancer during and after treatment as well as the feasibility of physical activity intervention in the RESPECT study (Rehabilitation including Social and Physical activity and Education in Children and Teenagers with Cancer---ClinicalTrials.gov: NCT01772862).[@R19]

Methods and design {#s2}
==================

Intervention design {#s2a}
-------------------

The RESPECT study is an integrated part of Centre for Integrated Rehabilitation of Cancer Patients---a research centre established and supported by the Danish Cancer Society and the Novo Nordisk Foundation aiming to explore how early-intervention strategies, including physical activity, influence rehabilitation of children and adults with cancer. The RESPECT study is a nationwide population-based, prospective, controlled and mixed methods intervention study. The children with cancer were activated and motivated to be physically and socially active during treatment by professional and psychosocial support. The evaluation of feasibility of the intervention is inspired by the criteria for reporting the development and evaluation of complex interventions in healthcare guidelines describing aims, the theoretical background, intervention components, strategy, motivations and barriers, and compliance.[@R20]

Physical intervention programme and setting {#s2b}
-------------------------------------------

The intervention programme was conducted by a trained exercise psychology consultant (first author, TT) in the paediatric oncology ward. The in-hospital intervention combined daily participation in supervised individual physical activity and group-based physical activities twice weekly with other children with cancer and healthy classmates (ambassadors). As part of the RESPECT study, the hospitalised children each had two healthy classmates assigned to them as ambassadors. The ambassadors visited the child with cancer at the hospital (9 a.m. to 3 p.m.) at alternating 2-week intervals and participated in the intervention programme. A more detailed description of the physical intervention has been reported previously.[@R19] [Supplementary file 1](#SP1){ref-type="supplementary-material"} outlines some of the most common exercises used in this intervention. Inclusion criteria for physical training sessions and physiological testing were developed in collaboration with the chief senior physician and professor at the paediatric oncology ward and were haemoglobin above 5 mmoL/L; platelets above 10 billion/L at moderate intense and intense exercise and by testing and above 50 billion/L in 'contact sport'; and consent from patients and parents. Exclusion criteria were temperature equal to or above 38.5°C; active diarrhoea, coughing, cold; and severe comorbidities that prevented physical activity.

10.1136/bmjsem-2016-000179.supp1

###### Supplementary data

Participants {#s2c}
------------

From January 2013 to April 2016, 75 of 78 consecutively eligible children (96.2%) were included in the RESPECT study. The group comprised children undergoing treatment for cancer at Copenhagen University Hospital. Eligibility criteria were: age 6‒18 years; diagnosed with cancer, Langerhans cell histiocytosis or myelodysplastic syndrome; treated with chemotherapy; enrolled in school at the time of diagnosis and able to communicate in Danish. Exclusion criteria were limited to mental disability (eg, Down's syndrome) or severe comorbidity. [Table 1](#T1){ref-type="table"} shows the demographic and clinical characteristics of the intervention population.

###### 

Demographic and clinical characteristics of the intervention population

  Variables                           n=75
  ----------------------------------- ------------------------
  Demographics                        
   Females/males                      29 (39%)/46 (61%)
   Age at diagnosis (median, range)   11 years (6--18 years)
   Danish ethnicity/other ethnicity   66 (88%)/9 (12%)
  Diagnoses                           
   Acute lymphoblastic leukaemia      24 (32.0%)
   Acute myeloid leukaemia            4 (5.3%)
   Myelodysplastic syndrome           V1 (1.3%)
   Acute promyelocytic leukaemia       2 (2.8%)
   Central nervous system tumour       8 (10.7%)
   Lymphoma                           14 (18.7%)
   Extracranial solid tumour          21 (28.0%)
   Langerhans cell histiocytosis       1 (1.3%)
  Location of tumours                 
   Upper limb                          8
   Lower limb                          7
   Torso (organs and  genitals)        5
   Brain                               8
  Treatment                           
   CT                                 48 (64.0%)
   CT+S                               15 (20.0%)
   CT+RT                               3 (4.0%)
   CT+RT+S                             9 (12.0%)
   Vincristine                        61 (81.3%)
   Stem cell transplantation          10 (13.3%)

CT, chemotherapy; RT, radiotherapy; S, surgery.

Physical tests {#s2d}
--------------

The intervention programme was quantified using the following physiological tests: VO~2peak~, Timed-Up-and-Go, Sit-to-Stand, Grip strength, Flamingo balance and Andersen Fitness test (see detailed description in [supplementary file 2](#SP1){ref-type="supplementary-material"}). Monitoring took place at diagnosis, 3 and 6 months after diagnosis and 1 year after cessation of treatment. Level of activity prediagnosis was collected at diagnosis (self-reported) and level of participation was registered after each training session.

Statistical analysis {#s2e}
--------------------

Measurements of the endpoints VO~2peak~, STS, TUG, Balance and Grip strength taken at four study time points (at diagnosis, 3 and 6 months after diagnosis and 1 year after cessation of treatment) are reported as mean and SD or median and IQR, as appropriate. Linear mixed models using a heterogeneous AR[@R1] covariance structure are used for evaluating change over time. The analyses are adjusted for the effect of diagnosis, gender and age, and the baseline measurements are further adjusted for the time from diagnosis to first measurement. Change scores, and their 95% CIs are estimated from the model parameters using the delta method. Heart rates of children with cancer and healthy classmates are compared using a linear mixed model in a data set with 294 heart rate measurements (163 from children with cancer and 131 from healthy classmates) from a total of 97 children (50 children with cancer and 47 healthy classmates). The age of the 50 children with cancer was median age 11 years (range 6--16) and 39.1% were girls. Comparisons with a normal population were made using an age- and gender-matched subsample from the reference data sets with five controls sampled for each child with cancer. The cardiorespiratory fitness norm values (mL/kg/min) for healthy children used for comparison were collected from Denmark, Norway, Estonia and Portugal.[@R21] For each time point differences between the children with cancer and the matched controls were compared using a Wilcoxon test. From these cohorts, data for each age group between 6 and 18 years were separated and mean values calculated. These were adjusted for cohort effects and the protocol used (treadmill or cycle test).[@R26] p Values below 0.05 (two-sided) were considered statistically significant.

Results {#s3}
=======

[Table 2](#T2){ref-type="table"} shows prediagnosis activity level, level of participation in the physical activity intervention, dropouts during the intervention, number of physiological test performed and time from diagnosis to baseline tests, safety measures as well as ambassador feasibility.

###### 

Prediagnosis activity level, level of participation, dropouts, physiological test performed, time from diagnosis to baseline and safety measures as well as ambassador feasibility

                                                                                     (n=75)
  ---------------------------------------------------------------------------------- --------------------
  Physical activity                                                                  
   Active before diagnosis\*                                                         33.3% (25/75)
   Not active before diagnosis\*                                                     66.6% (50/75)
   Participation in individual training sessions                                     100% (75/75)
   Participation in group training sessions                                          96% (72/75)
   Dropouts during intervention                                                      0% (0/75)
   Individual sessions per child, mean (range)                                       37 (8--83)
   Group sessions per child, mean (range)                                            8 (1--23)
   Individual training sessions                                                      \>3100
   Group training sessions                                                           \>300
   Number of physiological tests                                                     758
   Time from diagnosis to baseline test, median (IQR)                                8 days (4.5--19.0)
  Safety                                                                             
   Adverse events during training sessions and physiological testing^†^              5
   Restrictions in relation to physiological testing based on a medical assessment   20% (15/75)
  Ambassadors                                                                        
   Two ambassadors allocated                                                         100% (75/75)

\*Active defined as 60 min of moderate to vigorously activity three times per week.[@R34]

†Adverse events were four minor bruises during training sessions and one incident of a few seconds of fainting after a VO~2peak~ test.

[Table 3](#T3){ref-type="table"} shows the number of physiological tests conducted at different time points. The RESPECT study is an ongoing study, which explains the different numbers at different time points.

###### 

Number of physiological tests conducted at different time points

  ----------------------------------------------------------------------------------------------------------------------------------------
                    At diagnosis\   Three months after diagnosis\   Six months after diagnosis\   One year after cessation of treatment\
                    (n=75)          (n=68)                          (n=67)                        (n=16)
  ----------------- --------------- ------------------------------- ----------------------------- ----------------------------------------
  VO~2peak~         19 (25.3%)      19 (27.4%)                      19 (28.4%)                    13 (81.3%)

  Sit-to-stand      58 (77.3%)      50 (73.5%)                      45 (67.2%)                    14 (87.5%)

  Timed Up-and-Go   54 (72.0%)      48 (70.6%)                      44 (65.7%)                    15 (93.8%)

  Balance           64 (85.3%)      52 (76.5%)                      46 (68.7%)                    15 (93.8%)

  Grip strength     68 (90.7%)      55 (80.9%)                      48 (70.6%)                    15 (93.8%)
  ----------------------------------------------------------------------------------------------------------------------------------------

[Table 4](#T4){ref-type="table"} shows the different reasons for non-compliance to the VO~2peak~ test (1) medical restrictions, (2) not capable, (3) not motivated, (4) treatment compliance, (5) measurement error and (6) late inclusion.

###### 

Reasons for non-compliance to VO~2peak~ test

          Baseline   Three months   Six months   Cessation after 12 months                     
  ------- ---------- -------------- ------------ --------------------------- ----- ------ ---- ------
  1       16         28.6           12           23.5                        16    33.3   1    33.3
  2       28         50.0           30           58.8                        24    50.0   2    66.7
  3        3          5.4            4            7.8                         4     8.3   --   --
  4        3          5.4            3            5.9                         4     8.3   --   --
  5        3          5.4           --           --                          --    --     --   --
  6        3          5.4            2            3.9                        --    --     --   --
  Total   56         --             49           --                           48   --     3    --

Intensity during physiological testing and training sessions remained generally high. [Table 5](#T5){ref-type="table"} shows the relative intensity of the group training sessions monitored by heart rate over a period of 2 years from 1 September 2013 to 1 September 2015. Children with cancer had a higher average heart rate during training sessions than their healthy peers. [Table 5](#T5){ref-type="table"} also presents maximal heart rate and respiratory exchange ratio (RER) during VO~2peak~ testing.

###### 

Relative intensity monitored by heart rate and respiratory exchange ratio (RER)

  -------------------------------- ----------------------------- ----------------------- -------------- --------- ----------
  During group training sessions                                                                                  
  Variable                         Group                         Mean                    95% CI         p Value   
  HR~average~ (beats/min)          Children with cancer (n=50)   145.3                   141.7          148.9     \<0.0001
                                   Ambassador (n=47)             127.8                   123.5          131.1     
  HR~max~ (bpm)                    Children with cancer (n=50)   185.2                   180.8          189.5     0.0556
                                   Ambassador (n=47)             178.9                   174.3          183.6     
  During VO~2peak~ test                                                                                           
  Variable                         Group                         HR~max~ (median, bpm)   RER (median)             
  VO~2peak~ test                   Children with cancer          192                     1.23                     
  -------------------------------- ----------------------------- ----------------------- -------------- --------- ----------

Physiological test results {#s3a}
--------------------------

[Table 6](#T6){ref-type="table"} shows the statistics of the VO~2peak~ at the different time points, at diagnosis, at 3 and 6 months and 1 year after cessation of treatment, compared with a healthy age- and gender-matched control. Children with cancer had significantly lower VO~2peak~ (mL/kg/min) than age- and gender-matched controls sampled from population reference data at every time point.

The difference in numbers in [tables 4](#T4){ref-type="table"} and [6](#T6){ref-type="table"} is due to the exclusion of brain and bone tumours and stem cell transplantation (SCT). We excluded this group from the comparative analysis.

###### 

VO~2peak~ test results at different time points

                     Group              n    Median   25th percentile   75th percentile   p Value    Mean   SD     Difference of means
  ------------------ ------------------ ---- -------- ----------------- ----------------- ---------- ------ ------ ---------------------
  Diagnosis          RESPECT            17   30.4     24.7              34.1              \<0.0001   29.8   5.7    19.1 (15.4 to 22.7)
                     Matched controls   85   49.7     43.7              54.6                         48.9   7.1    
  3 months           RESPECT            19   27.7     23.9              29.7              \<0.0001   27.3   6.3    21.0 (17.4 to 24.6)
                     Matched controls   95   49.5     42.0              54.5                         48.4   7.4    
  6 months           RESPECT            16   23.6     20.0              36.1              \<0.0001   27.7   10.2   21.6 (17.3 to 25.8)
                     Matched controls   80   49.9     43.8              54.8                         49.2   7.3    
  Cess. +12 months   RESPECT            8    39.4     38.2              43.8               0.0072    40.6   4.7    6.9 (1.1 to 12.7)
                     Matched controls   40   48.4     41.5              54.3                         47.5   7.8    

[Table 7](#T7){ref-type="table"} shows the statistics and development of the physiological testing in children with cancer at diagnosis, 3 and 6 months postbaseline and 1 year after cessation of treatment. The analyses are adjusted for the effect of diagnosis, gender and age, and the baseline measurements are further adjusted for the time from diagnosis to first measurement. Change scores and their 95% CIs are estimated.

###### 

Shows the statistics and development of the physiological testing in children with cancer at diagnosis, 3 and 6 months postbaseline and 1 year after cessation of treatment

  Variables                  Time               Mean   95% CI   Change from diagnosis   95% CI           
  -------------------------- ------------------ ------ -------- ----------------------- -------- ------- ------
  VO~2peak~ (mL/kg/min)      Diagnosis          32.1   27.5     36.7                    --               
                             3 months           25.8   22.9     28.7                    −6.3     −10.8   −1.8
                             6 months           27.5   23.3     31.7                    −4.6     −9.9     0.8
                             Cess. +12 months   37.6   34.0     41.2                     5.5      0.3    10.7
  VO~2peak~ (L/min)          Diagnosis           1.4    1.1      1.6                    --               
                             3 months            1.2    1.0      1.4                    −0.2     −0.4     0.1
                             6 months            1.4    1.1      1.7                     0.0     −0.3     0.3
                             Cess. +12 months    1.9    1.6      2.2                     0.5     V0.2     0.8
  STS (repetitions)          Diagnosis          28.0   25.2     30.9                    --               
                             3 months           22.7   20.2     25.2                    −5.4     −8.2    −2.5
                             6 months           23.9   21.1     26.7                    −4.1     −7.6    −0.7
                             Cess. +12 months   29.5   26.3     32.7                     1.5     −2.3     5.2
  Timed-up-and-Go (time)     Diagnosis           3.7    3.4      4                      --               
                             3 months            4.5    4.2      4.8                     0.8      0.4     1.2
                             6 months            4.5    4.1      4.8                     0.8      0.3     1.2
                             Cess. +12 months    3.5    3.2      3.7                    −0.2     −0.6     0.2
  Grip strength left hand    Diagnosis          19.7   17.6     21.8                    --               
                             3 months           17.3   15.3     19.3                    −2.4     −4.2    −0.5
                             6 months           18.0   15.9     20.1                    −1.7     −4.0     0.5
                             Cess. +12 months   23.6   21.0     26.3                    V3.9      1.1     6.8
  Grip strength right hand   Diagnosis          21.5   19.1     23.8                    --               
                             3 months           19.0   17.0     20.9                    −2.5     −4.5    −0.4
                             6 months           20.7   18.4     23.1                    −0.8     −3.3     1.8
                             Cess. +12 months   25.9   23.4     28.5                     4.5      1.5     7.4

[Figure 1A--F](#F1){ref-type="fig"} shows the statistics and development of the physiological testing in children with cancer at diagnosis, 3 and 6 months postbaseline and 1 year after cessation of treatment. The connecting lines indicate the average development in physical performance during treatment.

![(A) VO~2peak~ (mL/kg/min), (B): VO~2peak~ (L/min), (C) Sit-to-Stand (repetitions, n), (D) Timed-up-and-Go (time, s) and (E,F) Grip strength (kg).](bmjsem-2016-000179f01){#F1}

Discussion {#s4}
==========

This study shows that it is safe and feasible to perform strenuous physical exercise and comprehensive physiological testing during treatment for paediatric cancer. Cardiorespiratory fitness is significantly lower than norms from age-matched healthy children at diagnosis, during treatment and even 1 year after cessation of treatment. A pronounced decline in physical capacity, muscle strength and physical function is present throughout the entire course of treatment and even small improvements could be considered vital and be the difference between living a normal everyday life and a life in constant dependency on others.

The RESPECT study is based on experiences from an unpublished pilot study, a theoretical framework, and earlier intervention studies of children with cancer. Reliable evidence on successful rehabilitation in children with cancer is lacking and we believe that RESPECT will contribute with novel relevant knowledge about treatment and rehabilitation of children with cancer and is probably also applicable to other children hospitalised with long-term illness.

Feasibility and safety {#s4a}
----------------------

All 75 children included in the RESPECT study took part in the physical activity sessions ([table 2](#T2){ref-type="table"}). Three children had no hospital admissions, but only a few outpatient visits and did not take part in group training sessions ([table 2](#T2){ref-type="table"}). Frequency and compliance mainly differed depending on diagnosis, inpatient days and level of side effects. There were no dropouts from the intervention programme ([table 2](#T2){ref-type="table"}). Thus, every child taking part in the intervention attended and completed the physical exercise sessions until either cessation of treatment or death.

We registered only five adverse events ([table 2](#T2){ref-type="table"}). This is a low number of incidents and determines our precautions, inclusion criteria and physical exercise and testing as appropriate.

Fifteen of 75 children had restrictions in relation to physiological testing based on a medical assessment ([table 2](#T2){ref-type="table"}). These cases related primarily to brain and bone tumours and SCT. We excluded this group from the comparative analysis ([table 6](#T6){ref-type="table"}).

From August 2012 to January 2013, we conducted an unpublished pilot study to test whether the components of the main study were feasible. The pilot study focused on the processes of the main study, safety measures, intervention scheme and physiological assessments. The pilot study indicated that we would be able to allocate two suitable ambassadors to more than 95% of patients, and that they will be able to cope with the challenges linked to their participation. Subsequently, during the intervention study, we have seen that it is possible to allocate ambassadors for all children and that the ambassadors were highly motivated for providing in-hospital patient support during childhood cancer therapy ([table 2](#T2){ref-type="table"}).[@R27]

Physical exercise and testing {#s4b}
-----------------------------

Due to the wide heterogeneity of the group ([table 1](#T1){ref-type="table"}), child-specific interests, individual aims and motivations to be physically active (Thorsteinsson T, Schmiegelow K, Andersen LB, et al. Classmates motivate childhood cancer patients to participate in physical activity during treatment: a qualitative study. European Journal of Cancer Care, submitted.), designing a safe and acceptable intervention with a high level of compliance requires tailoring. Furthermore, the physical ability of children with cancer fluctuates considerably and can change rapidly from day-to-day and even from hour-to-hour. To meet this challenge, the daily exercise sessions were tailored to each child's needs, age, gender, side effects, capabilities, fitness level, level of activity prediagnosis and support from their social network. Social and mental skills training were performed when the child with cancer was not able to perform physical exercise as well as during exercise sessions and social sessions. [Supplementary file 1](#SP1){ref-type="supplementary-material"} outlines the exercises primarily used in the physical training programme. The focus was on stability/balance, mobility, strength (resistance) and cardiorespiratory fitness. Several of the exercises affect more than one focus area. The feasibility of the test battery improved as we identified various challenges. The TUG, Flamingo balance, STS and Grip strength tests were easily implemented and could be carried out at the ward in the patient's room in approximately 10 min and compliance was acceptable ([table 3](#T3){ref-type="table"}). The VO~2peak~ test needed flexible access to test equipment, which were not available at the beginning of the study. Moreover, the window of opportunity to test children with cancer is very small due to their fluctuating well-being, low blood counts and need for medical procedures. Consequently, we purchased our own portable equipment, which led to an increase in the number of VO~2peak~ tests performed due to greater flexibility and access. As expected, compliance was low in the number of VO~2peak~ tests performed in contrast to the other test, and there seems to be an association between the number of tests performed and the length and intensity of the test ([table 3](#T3){ref-type="table"}). Furthermore, it seems like the decline in physical capacity and strength and consequently reduced physical function during treatment affects the completion rate of physical tests ([table 3](#T3){ref-type="table"}). The reasons for not performing the test were mainly severe treatment side effects, medical procedures or medical restrictions ([table 4](#T4){ref-type="table"}). Reasons for better compliance in TUG, Flamingo balance, STS and Grip strength tests were primarily the reduced length and intensity of the test, easier to complete despite pain and discomfort, fewer restrictions and physically and mentally less demanding. Future interventions should possibly also include a submaximal VO~2~ test to enhance the number of tests performed, even though we believe the current VO~2peak~ test shows novel and interesting results.

We excluded the modified flamingo balance test in this study, because the results varied widely. We also excluded the modified Andersen test from the test battery, as we learnt it was not compatible in children with cancer and could not produce a fitness rating similar to the VO~2peak~ test, probably because of our small modification as well as the test has not been validated in a group with such low performance scores.

Intensity during physical exercise sessions {#s4c}
-------------------------------------------

During group training sessions, we monitored the children's heart rate and found it to be very high even during low-intensity exercise ([table 5](#T5){ref-type="table"}). Children with cancer had a higher average heart rate during training sessions than their peers. Whether this is due to increased metabolism (increased cell division), poor fitness, physical and/or mental stress, severe illness, low blood counts or severe treatment is unknown. We believe it is mainly due to the poor fitness, but this should be investigated further. This implicates that children with cancer may have severe challenges during everyday activities, such as walking and running and other movements which are typical for children and require aerobe capacity.

Physical capacity and functionality {#s4d}
-----------------------------------

The comprehensive monitoring shows that cardiorespiratory fitness is already significantly lower in children with cancer at diagnosis when compared with healthy children ([table 6](#T6){ref-type="table"}). Physiological test results at diagnosis correlate well with the results from Ness *et al* [@R29] and are a strong advocate for early rehabilitation. Starting rehabilitation at diagnosis is pivotal to preserve physical function and prediagnosis habits. The pronounced decline in physical capacity, muscle strength and physical function is present throughout the entire course of treatment ([table 7](#T7){ref-type="table"}, [figure 1A--F](#F1){ref-type="fig"}). Even at a moderate level of exercise (eg, short walks and other low-intensity activities at moderate pace), heart rate quickly rose above 170 bpm. As a consequence, children with cancer were often only capable of doing exercise or everyday activity in very short intervals, even though the absolute workload normally would be considered low-to-moderate. Accordingly, due to decreased physical fitness of these children, simple everyday activities should be considered so strenuous that they are equivalent to moderate to intense physical training. An earlier study showed that regular everyday physical exercise, such as cycling to school, constitutes physical activity that has positive effects even in healthy children.[@R30] As mentioned earlier, reducing the daily activity level is associated with negative metabolic consequences. A study by Olsen *et al* [@R31] assessed metabolic changes when reducing daily steps and found that young healthy men developed metabolic changes indicative of decreased insulin sensitivity, attenuation of postprandial lipid metabolism and physical changes suggesting that calories used to maintain muscle mass with greater stepping may have been partitioned to visceral fat. As a result, if children with cancer are capable of maintaining an as normal as possible activity level, this actually constitutes moderate- to high-intensity physical activity and may be beneficial for a range of health outcomes.

We have presented cardiorespiratory fitness as a general fitness level and as absolute oxygen uptake because the weight component is essential. Children with cancer often experience a big weight gain during treatment.[@R32] Some children with cancer are able to maintain or improve their level of VO~2peak~ (L/min) from diagnosis to 3 and 6 months after diagnosis, with only their weight is altering. To validate the VO~2peak~ test, we looked at median heart rate and RER. We observed that the median heart rate was 192 bpm and that the median RER was 1.23, which shows the same development in heart rate during testing as in healthy children; accordingly we have high validity of the VO~2peak~ testing ([table 5](#T5){ref-type="table"}).

As shown in [table 7](#T7){ref-type="table"} and [figure 1](#F1){ref-type="fig"}, muscle strength and physical function were declined at diagnosis ([table 7](#T7){ref-type="table"}, [figure 1C-- F](#F1){ref-type="fig"}), which is in agreement with the results from Ness *et al* [@R29] A highly sedentary lifestyle and everyday life with a serious illness and associated side effects cause a further drastic decline in muscle strength, physical function and balance. STS, balance and TUG performance indicate whether or not a person is fit to move around without any restrictions or special needs and participate in normal everyday activities (eg, climbing stairs, moving from one place to another) whether at home or at school. Grip strength measurement by dynamometry is well standardised, and grip strength correlates with a number of important life functions (eg, self-care, carrying bags, doing homework, opening doors and bottles, etc).[@R33] To our knowledge there are no norms in healthy children in the STS and TUG test.

Perspectives and conclusion {#s5}
===========================

This study shows that it is safe and feasible to perform strenuous physical exercise and testing during paediatric cancer treatment and that children with cancer have a significantly lower cardiorespiratory fitness than healthy age-matched norms even 1 year after cessation of treatment. A pronounced decline in muscle strength and physical function is present throughout treatment. These results reveal that there is a need to re-think rehabilitation in children diagnosed and treated for cancer. Comprehensive professional and psychosocial support, enhancing social and physical activity is a new and highly recommended way forward. The present results can be transferred to a different or similar context and setting relating to rehabilitation of children hospitalised with and burdened by long-term illnesses.
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